In-situ Hybridization Market, By Product Type (Reagents, Assay Kits and Probes, and Instruments), By Hybridization Technique (Chromogenic In-Situ Hybridization and Fluorescence In-Situ Hybridization), By Application (Infectious Diseases, Cytogenetics, Immunology, Cancer Diagnosis, Developmental Biology, and Others), By End-User (Diagnostic Laboratories, Pharmaceutical and Biotech Companies, Research and Academic Institutes, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI12719 | Publish Date: March 2024 | No. of Pages: 170

Global Insitu Hybridization Market By Overview

In-situ Hybridization Market was valued at US$ 2 Billion in 2024 and is projected to grow at a CAGR of 13.10% to reach US$ 6.1 Billion by 2034.

In-situ hybridization is a technique that allows scientists to locate the position of precise DNA/RNA sequences in the chromosome. The nucleic acid probe is produced, labeled, purified, and annealed with the exact target. It is a vital method in genetic research and discovery of gene-based medicine, particularly in personalized medicine. In situ hybridization is fragmented into two types; chromogenic in-situ hybridization (CISH) and fluorescence in-situ hybridization (FISH). Among of, FISH permits to visualize manifold targets in the same sample and is primarily appropriate for the detection of a specific gene, a number of copies of gene and mutation analysis in the same sample. The CISH allows gaining genetic information in context of tissue morphology and is also mainly applicable to molecular biology.

In-situ hybridization has wide human application especially FISH, which primarily used for clinical diagnosis of chronic diseases include immune diseases, cancer, and rare diseases triggered by chromosome abnormalities. Hence, increasing incidence of above-mentioned diseases is a major factor driving the global in-situ hybridization market during the forecast period. For instance, according to the National Institute of Health, a rare disease usually affects a patient population estimated below 200,000 in the U.S. There are more than 6,000 rare diseases known today and they affect an estimated 25 million persons in the U.S.  Thus, the data represent a huge demand for analytical technique such as ISH, which is likely to propel the global market over the forecast period. 

However, the presence of alternatives approach for clinical diagnosis and high cost may hamper the global in-situ hybridization market growth in the coming years. 

Global Insitu Hybridization Market By Segmentation

The in-situ hybridization market has been segmented on the basis of product type, hybridization technique, application, end user, and region.

The product type segment includes Reagents, Assay Kits and Probes, and Instruments. Further, on the basis of hybridization technique, the global in-situ hybridization market is fragmented into the chromogenic in-situ hybridization and fluorescence in-situ hybridization. 

Based on the application, the global market is divided into infectious diseases, cytogenetics, immunology, cancer diagnosis, developmental biology, and others. Moreover, the end-user segment includes diagnostic laboratories, pharmaceutical, and biotech companies, research and academic institutes, and others.

On the basis of region, the target market has been categorized into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. 

Global Insitu Hybridization Market By Key Players

Key players operating in the global in-situ hybridization market includes Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, PerkinElmer, Inc., Merck KGaA, Oxford Gene Technology, Exiqon A/S, BioGenex Laboratories, Inc., Leica BiosystemsNussloch GmbH, Advanced Cell Diagnostics, Inc., and Bio SB Inc.

Global Insitu Hybridization Market By Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Hybridization Technique
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map
  3. Market Dynamics
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Global In-situ Hybridization Market, By Product Type, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Reagents
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Assay Kits and Probes
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Instruments
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  5. Global In-situ Hybridization Market, Hybridization Technique, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Chromogenic In-Situ Hybridization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Fluorescence In-Situ Hybridization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
  6. Global In-situ Hybridization Market, Application, 2018 – 2028,
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Cytogenetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Immunology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Cancer Diagnosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Developmental Biology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
  7. Global In-situ Hybridization Market, By End User, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Pharmaceutical and Biotech Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Research and Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2028, (US$ Mn)
  8. Global In-situ Hybridization Market, By Region, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  U.S.

Ø  Canada

    • Latin America
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile

Ø  Rest of Latin America

    • Europe
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Germany

Ø  U.K.

Ø  France        

Ø  Italy

Ø  Spain

Ø  Russia

Ø  Rest of Europe

    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

    • Middle East
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

    • Africa
      • Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Hybridization Technique, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By End Users, 2018 – 2028
      •  Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  South Africa

Ø  Central Africa

Ø  North Africa

  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Abbott Laboratories, Inc.*

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Agilent Technologies, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Thermo Fisher Scientific, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • F. Hoffmann-La Roche AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Merck KGaA

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • PerkinElmer, Inc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Oxford Gene Technology

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

      • Leica BiosystemsNussloch GmbH

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

    • Analyst Views
  1. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The in-situ hybridization market has been segmented on the basis of product type, hybridization technique, application, end user, and region.

Restraints of In-situ Hybridization Market: Complexity in assay design and optimization, potential technical challenges, and limited expertise in certain regions.

Factors Driving In-situ Hybridization Market: Growing applications in cancer diagnosis, advancements in molecular diagnostics, and increasing demand for personalized medicine and targeted therapies.

By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

Key players operating in the in-situ hybridization market includes Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, PerkinElmer, Inc., Merck KGaA, Oxford Gene Technology, Exiqon A/S, BioGenex Laboratories, Inc., Leica BiosystemsNussloch GmbH, Advanced Cell Diagnostics, Inc., and Bio SB Inc.